Indian Startup to Launch Online Rare Cancer Test

India Startup to launch rare Cancers test in Kolkata, a Chennai-based personalised medicine start-up is all set to launch advanced tests for precise identification.
Swagene, one of the winners at Empresario 2016 at IIT-Kharagpur’s annual global business model competition, has developed tests for sarcomas (soft tissue cancers) such as rhabdomyosarcoma, synovial sarcoma and Ewing’s sarcoma (bone cancer) which shall be launched in February, according to the reports.
Ratnakumar and his team intend to bring advanced diagnostics to the market and make them accessible and affordable to the public, finds the right therapy for patients based on genetic analysis, looks at three broad areas: infertility, cardiology and oncology.
According to Sooraj Ratnakumar Founder of Swagene, “There is a market need for diagnostics of these cancers as it is very difficult to distinguish between these three and the market is not satisfying this particular need. We will launch the tests in early February.”
“We go meet doctors and convince them about the tests we do, 50 percent of the tests are completely novel in this geography. For example, in infertility we identify who are the poor responders in IVF and how to overcome the poor response.”
Accordance to Ratnakumar (a molecular biologist from Cambridge University, who also spearheads the R&D at Swagene), “We look at specific disease-markers and diagnose and advise the patient and their doctors on how to proceed with therapy. For example, those therapies will work for them, which will give them severe side-effects and how to avoid those side-effects and what will not work for them.”
The tests can be ordered online anywhere in India.